Azulfidine En-Tabs Oral Tablet, Gastro-Resistant 500Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Azulfidine En-Tabs: Oral tablet, gastro-resistant (500mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_772.JPG
Azulfidine ENtabs 500mg DR Tab
Pfizer Inc.
Pill Identification: KPh  |  102

What is this Medicine?

SULFASALAZINE (sul fa SAL a zeen) is for ulcerative colitis and certain types of rheumatoid arthritis.

CVS Pharmacy Patient Statistics for Azulfidine En-Tabs: Oral tablet, gastro-resistant(500mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Azulfidine EN-tabs 500mg Delayed-Release Tablet

NDC: 000130102
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Rheumatoid Arthritis, Ulcerative Colitis, Juvenile Rheumatoid Arthritis (JRA)/juvenile Idiopathic Arthritis (JIA)

Sometimes used for but not FDA approved for the following conditions:
Crohn's Disease

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Azulfidine EN-tabs 500mg Delayed-Release Tablet
Drug Image file DrugItem_772.JPG
Pfizer Inc.
Pill Identification: KPh  |  102
Shape: oval
Color: yellow

Reported Side Effects for Azulfidine EN-tabs 500mg Delayed-Release Tablet

Cyanosis Incidence:
<3.3%*
Severity: SEVERE
Onset: EARLY
Skin Rash Incidence:
<13.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
<3.3%*
Severity: MILD
Onset: RAPID
Diuresis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Low Blood Sugar Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Hemolytic Anemia Incidence:
<3.3%*
Severity: SEVERE
Onset: DELAYED
Enlarged Thyroid Gland Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
<4.0%*
Severity: MILD
Onset: RAPID
Low Platelet Count Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Mouth Ulcers Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
8.0-33.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
9.0-33.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
13.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
19.0-33.0%*
Severity: MILD
Onset: EARLY
Low Sperm Count Incidence:
33.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
33.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
First Trimester

Class 2 - Risk Documented in Humans

Second Trimester

Class 6 - Unknown Risk

Third Trimester

Class 2 - Risk Documented in Humans

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Azulfidine En-Tabs

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5